Skip to content

Press Releases

July 22, 2019

SBP Provides an Update on Ongoing Front-line Pancreatic Cancer Clinical Trial

  • Preliminary Efficacy Signals Seen with SBP-101 Administered in Combination with Gemcitabine and Nab-paclitaxel
  • DSMB Approves Enrollment of 3rd and Final Cohort

View/download press release »

Sign up to receive press releases via email